Moreover, Schmitz et al. identified an immunogenic CD8+ T cell epitope derived from SOX11 [21], which emphasized the suitability of SOX11 as a promising novel target for the immunotherapy of malignant gliomas. This evidence concerns the gene SOX11 and malignant glioma.